Part of the Will Luigi Mangione be convicted of criminal charges? topic →
This market asks whether Mangione will plead guilty to or be found guilty of any New York state criminal charge by January 1, 2027. The state murder and weapons case has not gone to trial: the scheduled September trial was canceled while the judge considers the defense argument that the federal plea bars the state prosecution under New York law. The parties’ briefing and a December 10 court date leave the case unresolved, and reporting describes meaningful legal uncertainty about whether it can proceed. Even if the motion is denied, the remaining time before the resolution date makes a state conviction difficult; no directly matching external probability was available.
On August 17, Justice Gregory Carro paused the state case and set deadlines for the prosecution’s response to the defense motion. The planned September trial will not proceed on its original timetable; the state charges remain pending with no dismissal or verdict reported.
Mangione's attorneys filed a motion to dismiss the state murder case, arguing New York law prohibits prosecuting someone twice for the same crime after a federal guilty plea. State prosecutors say they remain committed to pursuing a conviction.
Mangione admitted in court to shooting and killing UnitedHealthcare CEO Brian Thompson, marking a dramatic guilty plea in the federal case.
Judge Gregory Carro ordered an anonymous jury on August 11, 2026, citing realistic and substantial risk of harassment, intimidation, or improper influence on prospective and sworn jurors.
Judge Gregory Carro confirmed jury selection will begin September 8, 2026 for the state murder trial in Manhattan. The trial is expected to last 6-8 weeks.
